Atlantic Pharma – Pharmaceutical Productions S.A.
PolandAll drugs from this manufacturer
-
The medicine is used to relieve the symptoms of schizophrenia in adults (from 18 years of age) and in adolescents aged 13-17 years.
Dosage form: tablets, film-coated
Active substance Dosage lurasidone 18.62 mg ATC: N05AE05
-
The medicine is used to relieve the symptoms of schizophrenia in adults and in adolescents aged 13 to 17 years.
Dosage form: tablets, film-coated
Active substance Dosage lurasidone 37.24 mg ATC: N05AE05
-
The medicine is used to relieve the symptoms of schizophrenia in adults (from 18 years of age) and in adolescents aged 13-17 years.
Dosage form: tablets, film-coated
Active substance Dosage lurasidone 74.49 mg ATC: N05AE05
-
The medicine is used to treat erectile dysfunction (impotence) in adult men, i.e., in situations where an erection cannot be obtained or maintained sufficiently for sexual intercourse.
Dosage form: tablets, film-coated
Active substance Dosage sildenafil citrate 140.48 mg ATC: G04BE03
-
The medicine is used to treat symptoms of an overactive bladder, such as sudden and urgent need to urinate, frequent urination, and urinary incontinence.
Dosage form: tablets, film-coated
Active substance Dosage solifenacin succinate 5 mg ATC: G04BD08
-
This medicine is used to treat symptoms of an overactive bladder, such as sudden and urgent needs to urinate, frequent urination, and urinary incontinence.
Dosage form: tablets, film-coated
Active substance Dosage solifenacin succinate 10 mg ATC: G04BD08